Marimed (MRMD) Tax Provisions (2018 - 2026)
Marimed's (MRMD) quarterly Tax Provisions came in at $2.7 million in Q1 2026, down 6.36% year-on-year from $2.8 million in Q1 2025, and up 198.66% on a QoQ basis from -$2.7 million in Q4 2025.
Marimed (MRMD) Tax Provisions (2018 - 2026) Analysis & Trends
Marimed (MRMD) has 9 years of Tax Provisions data on file, last reported at $2.7 million in Q1 2026.
- On a quarterly basis, Tax Provisions fell 6.36% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $3.4 million, a 63.29% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, down 55.95% from the prior year.
- Tax Provisions for Q1 2026 stood at $2.7 million, up from -$2.7 million in the prior quarter.
- Over the last five years, Tax Provisions for MRMD reached as high as $4.9 million in Q4 2024 and fell as low as -$2.7 million in Q4 2025.
- Historically, Tax Provisions has averaged $1.7 million across 5 years, with a median of $1.9 million in 2023.
- Across the five-year window, Tax Provisions jumped 872.1% in 2024 and plunged 154.3% in 2025, its largest moves.
- Year by year, Tax Provisions stood at -$2.0 million in 2022, then soared by 125.53% to $509000.0 in 2023, then soared by 872.1% to $4.9 million in 2024, then plunged by 154.3% to -$2.7 million in 2025, then jumped by 198.66% to $2.7 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $2.7 million in Q1 2026, -$2.7 million in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Marimed | 25.83 Mn | 17.90 Mn | 15.28 Mn | 2.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | -2.69 Mn |
| Sep 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 691,000.00 |
| Mar 31, 2025 | 2.83 Mn |
| Dec 31, 2024 | 4.95 Mn |
| Sep 30, 2024 | 655,000.00 |
| Jun 30, 2024 | 866,000.00 |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 509,000.00 |
| Sep 30, 2023 | 4.46 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 2.49 Mn |
| Dec 31, 2022 | -1.99 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 3.66 Mn |
| Dec 31, 2021 | 7.17 Mn |
| Sep 30, 2021 | 4.01 Mn |
| Jun 30, 2021 | 3.81 Mn |